Humata Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 35)
Humata Health logo

Humata Health

EmergingDigital Health

Prior Authorization AI (Provider Side)

Raised $25M (Blue Venture Fund, Optum Ventures, Highmark Ventures). 225+ hospitals. ML recommends which clinical documents to include in prior auth submissions, reducing denials before submission.

AI VisibilityBeta
Overall Score
D35
Category Rank
#538 of 596
AI Consensus
84%
Trend
stable
Per Platform
ChatGPT
36
Perplexity
36
Gemini
40

About

Humata Health is a prior authorization AI platform serving the provider side of healthcare — helping hospital systems optimize their prior authorization submissions to reduce denial rates before claims are ever sent to payers. The company has raised $25 million from Blue Venture Fund, Optum Ventures, and Highmark Ventures, and is deployed at 225+ hospitals. Founded by an MD, the platform applies ML to recommend the specific clinical documentation that each payer's prior authorization algorithm weights most heavily.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

35
Overall Score
90
#538
Category Rank
#2
84
AI Consensus
83
stable
Trend
stable
36
ChatGPT
92
36
Perplexity
93
40
Gemini
89
40
Claude
96
34
Grok
95

Key Details

Category
Prior Authorization AI (Provider Side)
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Humata Health
Prior Authorization AI (Provider Side)

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.